氢分子医学分享 http://blog.sciencenet.cn/u/孙学军 对氢气生物学效应感兴趣者。可合作研究:sunxjk@hotmail.com 微信 hydrogen_thinker

博文

诺奖热身:CRISPR-CAS技术挺进加拿大盖尔德纳奖 精选

已有 6621 次阅读 2016-3-24 07:30 |个人分类:自然科学|系统分类:海外观察

 加拿大盖尔德纳奖素有“小诺贝尔奖”之称,至今313名获奖者中已经有80名后来获得了诺贝尔生理学或医学奖。加拿大盖尔德纳奖于1959年由加拿大盖尔德纳基金会创设,主要奖励在世界医学领域有重大发现和贡献的科学家。加拿大盖尔德纳国际奖每年评出五名获奖者、加拿大盖尔德纳全球健康奖和加拿大盖尔德纳怀特曼奖则各评出一名。

2016年加拿大盖尔德纳奖(Canada Gairdner Awards)的获得者名单,每位获奖者将分别获得10万加元奖金。

今年的7位获奖者中,有5位是目前最热门的CRISPR-CAS技术,另外两位是艾滋病和病毒感染方面的学者,华人科学家张峰排第一位。当然如果能获得诺贝尔奖,最多他们中只有3位入围。


Recipientof the Canada Gairdner International Award, 2016

"fordevelopment of CRISPR-CAS as a genome editing tool for eukaryotic cells"

CoreMember, Broad Institute of MIT and Harvard; Investigator, McGovern Institutefor Brain Research, Massachusetts Institute of Technology; W. M. Keck CareerDevelopment Professor in Biomedical Engineering, Departments of Brain andCognitive Sciences and of Biological Engineering, Massachusetts Institute ofTechnology; Cambridge, Massachusetts, USA; Robertson Investigator, New YorkStem Cell Foundation

FengZhang is a Core Member at the Broad Institute of MIT and Harvard, anInvestigator at the McGovern Institute for Brain Research at MIT, and anAssistant Professor in the Department of Brain and Cognitive Sciences. He wasborn in Shijiazhuang (Hebei Province, China) in 1981 and moved to Des Moines,Iowa in 1993. His introduction to engineering biological tools for mammaliansystems began as a sophomore in high school with an opportunity to intern inthe gene therapy lab of John Levy in Des Moines, Iowa. He obtained an A.B. inChemistry and Physics from Harvard University in 2004 working with XiaoweiZhuang. As a PhD student in the Chemistry Department at Stanford University,Zhang worked with Karl Deisseroth to develop optogenetics technologies fordissecting brain circuits, using light-sensitive proteins from microbes to enablecontrol of neuronal activity in living organisms with light. After finishinghis Ph.D. in 2009, Feng joined the Harvard Society of Fellows as a JuniorFellow (2009-2010), focusing on developing gene editing tools based ontranscription activator-like effectors (TALEs). In 2011, Zhang began his ownlaboratory at the Broad and McGovern Institutes, where he harnessed CRISPR-Cassystems for gene editing in eukaryotic cells. His lab continues to play acritical role in the development of gene editing technologies and applicationsthat are accelerating research around the world.


CurrentWinners

FengZhang

CanadaGairdner International Award

"fordevelopment of CRISPR-CAS as a genome editing tool for eukaryotic cells"

 


Jennifer Doudna

CanadaGairdner International Award

"fordevelopment of CRISPR-CAS as a genome editing tool for eukaryotic cells"

 


Emmanuelle Charpentier

Canada Gairdner International Award

"for development of CRISPR-CAS as a genome editing toolfor eukaryotic cells"

 


Philippe Horvath

CanadaGairdner International Award

" forestablishing and characterizing CRISPR-Cas bacterial immune defensesystem"

 


Rodolphe Barrangou

CanadaGairdner International Award

"forestablishing and characterizing CRISPR-Cas bacterial immune defensesystem"

 


Anthony Fauci

CanadaGairdner Global Health Award

"forhis many pioneering contributions to our understanding of HIV infections andhis extraordinary leadership in bringing successful treatment to the developingworld"

 


Frank Plummer

CanadaGairdner Wightman Award

"forhis groundbreaking research in Africa in understanding HIV transmission and hisleadership at the Canadian National Microbiology Laboratory with pivotal rolesin SARS, influenza and Ebola epidemics"

 



https://blog.sciencenet.cn/blog-41174-964536.html

上一篇:重大进展:CRISPR-Cas9首次实现RNA编辑
下一篇:左旋肉碱通过肠道细菌促进血栓形成
收藏 IP: 58.247.243.*| 热度|

7 罗德海 谢平 陈钢 wqhwqh333 biofans XY shenlu

该博文允许注册用户评论 请点击登录 评论 (1 个评论)

数据加载中...
扫一扫,分享此博文

Archiver|手机版|科学网 ( 京ICP备07017567号-12 )

GMT+8, 2024-4-30 19:01

Powered by ScienceNet.cn

Copyright © 2007- 中国科学报社

返回顶部